Location History:
- Giussago, IT (2015)
- Gropello Cairoli, IT (2017)
Company Filing History:
Years Active: 2015-2017
Title: Matteo Curti: Innovator in Pharmaceutical Purification Processes
Introduction
Matteo Curti is a notable inventor based in Gropello Cairoli, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the purification of important compounds. With a total of two patents to his name, Curti's work focuses on enhancing the purity and efficacy of pharmaceutical agents.
Latest Patents
Curti's latest patents include a process for the purification of melphalan and a synthesis method for nucleosides. The purification process for melphalan describes a method that achieves a purity level higher than 99.5%. This advancement is crucial for ensuring the effectiveness of melphalan in medical applications. The synthesis of nucleosides patent outlines a process for preparing nucleosides and their derivatives through a coupling reaction. This method is particularly beneficial for creating antiviral and antitumor agents, with a focus on achieving a residual tin content lower than 300 ppm.
Career Highlights
Matteo Curti is currently associated with Farmabios S.p.a., a company that specializes in pharmaceutical products. His work at Farmabios has allowed him to apply his innovative techniques in a practical setting, contributing to the development of high-purity pharmaceutical compounds.
Collaborations
Curti collaborates with notable colleagues, including Claudio Gianluca Pozzoli and Valentina Canevari. These partnerships enhance the research and development efforts within the company, fostering an environment of innovation.
Conclusion
Matteo Curti's contributions to pharmaceutical purification processes exemplify the impact of innovation in the medical field. His patents not only advance the science of drug preparation but also improve the quality of treatments available to patients.